
May is Mental Health Awareness Month. In this article, we’ll focus on dual diagnosis – the co-occurrence of mental health and substance use disorders—specifically, self-medication and the complex relationship between ADHD and addiction.
Attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD) frequently occur together, creating a challenging dual diagnosis that requires specialized treatment approaches. Research consistently shows that individuals with ADHD face a significantly higher risk of developing substance use problems compared to the general population.
Recent studies indicate that approximately 23% of adults seeking treatment for alcohol and substance use disorders also have ADHD. Among adolescents with substance use disorders, the prevalence of ADHD is even higher, with some studies reporting rates of 30-40%.
ADHD is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with functioning and development. The disorder often begins in childhood but can persist into adulthood for many individuals.
The three primary types of ADHD include:
For those with ADHD, everyday tasks that require sustained focus, organization, or patience can be extraordinarily challenging. The constant struggle to meet expectations at school, work, or in relationships can lead to frustration, low self-esteem, and a search for relief, which sometimes leads to substance use.
One of the most significant links between ADHD and substance use disorders is the concept of self-medication. Many individuals with undiagnosed or untreated ADHD turn to substances as a way to manage their symptoms. Specifically, studies have shown that individuals struggling with ADHD were more likely to use cocaine, non-prescription stimulants, and amphetamines.
People with ADHD often report using substances to:
Unfortunately, what begins as an attempt to self-manage symptoms often develops into dependence and addiction. The temporary relief substances provide is usually followed by worsening ADHD symptoms when the effects wear off, creating a dangerous cycle.
Several factors contribute to the increased risk of substance use disorders in individuals with ADHD:
ADHD involves differences in brain structure and function, particularly in areas related to reward processing and impulse control. These same brain regions are implicated in addiction development. The dopamine system, which plays a central role in ADHD, is also the primary target of many addictive substances.
The impulsivity associated with ADHD can lead to difficulty considering long-term consequences before acting. This tendency toward impulsive decision-making can increase the likelihood of experimental substance use becoming regular use.
Many people with ADHD also experience anxiety, depression, or other mental health challenges. This “triple diagnosis” situation further increases the risk of substance use as a coping mechanism.
The difficulties that many with ADHD face in social situations or academic settings can lead to feelings of rejection or failure. These negative experiences may increase vulnerability to peer pressure around substance use or lead to using substances to cope with negative emotions.
While any substance can become problematic, research shows certain substances are more commonly used by individuals with ADHD:
Effectively treating co-occurring ADHD and substance use disorders requires an integrated approach that addresses both conditions simultaneously. At Porch Light Health, we recognize the importance of comprehensive care for dual diagnosis patients.
Contrary to past concerns, research now shows that appropriate medication treatment for ADHD reduces the risk of substance abuse. Studies indicate that individuals receiving proper ADHD medication management experience up to a 60% reduction in substance use disorders compared to those not receiving treatment.
When treating ADHD in individuals with a history of substance use, providers may consider:
Several therapeutic approaches show effectiveness for dual diagnosis treatment:
Our behavioral health services integrate these evidence-based approaches to provide comprehensive support.
Peer support can be invaluable for individuals with a dual diagnosis. Groups specifically designed for those with both ADHD and substance use disorders provide understanding and practical strategies from others with similar experiences. Our community partnerships enhance these support networks.
Breaking the cycle of addiction and self-medication is possible, and at Porch Light Health, we’re committed to helping you find your path to recovery. We understand that ADHD and substance use disorders require specialized, integrated care that addresses both conditions simultaneously.
Across our network of over 60 locations throughout Colorado and New Mexico, our compassionate team provides comprehensive dual diagnosis treatment tailored to your unique needs. We begin with a thorough assessment to understand the complete picture of your mental health and substance use patterns. From there, we develop a personalized treatment plan that may include evidence-based Medication for Addiction Treatment (MAT), ADHD medication management, and behavioral health therapy with providers experienced in dual diagnosis.
If you or someone you love is struggling with both ADHD and substance use, you’re not alone. The cycle of self-medication can be broken, and recovery is possible.
Contact Porch Light Health today at (866) 394-6123 to schedule an assessment or learn more about our dual diagnosis treatment options. Our compassionate team understands the unique challenges you face and is ready to support your journey to wellness.
Remember: Mental health and substance use disorders are medical conditions, not moral failures. With proper treatment, you can experience life beyond addiction.
1. Zulauf, C. A., Sprich, S. E., Safren, S. A., & Wilens, T. E. (2014). The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders. Current psychiatry reports, 16(3), 436. https://doi.org/10.1007/s11920-013-0436-6
2. Magnus W, Anilkumar AC, Shaban K. Attention Deficit Hyperactivity Disorder. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441838/
3. Holborn, T., Schifano, F., Smith, E., & Deluca, P. (2025). The Use of Novel Stimulants in ADHD Self-Medication: A Mixed Methods Analysis. Brain Sciences, 15(3), 292. https://doi.org/10.3390/brainsci15030292
4. Gehricke, J. G., Kruggel, F., Thampipop, T., Alejo, S. D., Tatos, E., Fallon, J., & Muftuler, L. T. (2017). The brain anatomy of attention-deficit/hyperactivity disorder in young adults – a magnetic resonance imaging study. PloS one, 12(4), e0175433. https://doi.org/10.1371/journal.pone.0175433





